tradingkey.logo
tradingkey.logo
Search

Lisata Therapeutics Inc

LSTA
Add to Watchlist
0.990USD
-0.040-3.87%
Close 07-31 16:00ETQuotes delayed by 15 min
8.75MMarket Cap
LossP/E TTM

LSTA Financials

See Lisata Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Lisata Therapeutics Inc Earnings Date

Latest Release
May 11, 2026
EPS / Forecast
-0.50/--
Revenue / Forecast
--/--
Period
FY2025 Earnings
Revenue(YoY)
170.00K
-83.00%
EPS(YoY)
-1.91
20.43%
Analyst Rating
HOLD
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
9.24%-0.50
38.88%-0.34
17.93%-0.49
10.82%-0.54
15.67%-0.55
16.66%-0.55
8.32%-0.59
-20.93%-0.61
15.94%-0.65
13.18%-0.66
---0.65
---0.50
---0.77
---0.76
---11.28
----
----
----
----
----
Revenue
----
-90.00%100.00K
--0.00
--70.00K
----
--1.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Net Profit
4.97%-4.49M
35.92%-2.95M
13.81%-4.25M
7.63%-4.66M
12.53%-4.72M
14.07%-4.61M
6.29%-4.93M
-25.25%-5.04M
12.70%-5.40M
10.43%-5.37M
85.93%-5.26M
39.22%-4.03M
-46.40%-6.19M
11.83%-5.99M
-439.67%-37.38M
-16.61%-6.63M
47.59%-4.23M
-25.10%-6.79M
-30.04%-6.93M
-186.12%-5.68M
Net Margin
----
-540.78%-2954.00%
----
---6655.71%
----
---461.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
----
0.00%100.00%
----
--100.00%
----
--100.00%
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Revenue
----
-90.00%100.00K
--0.00
--70.00K
----
--1.00M
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Operating profit
15.48%-4.94M
37.79%-3.08M
17.28%-4.41M
11.86%-4.87M
11.42%-5.85M
17.86%-4.95M
10.53%-5.34M
19.67%-5.52M
3.55%-6.60M
7.87%-6.03M
18.60%-5.96M
-2.31%-6.88M
-3.38%-6.84M
4.51%-6.54M
-5.15%-7.33M
5.97%-6.72M
18.13%-6.62M
-25.76%-6.85M
-30.24%-6.97M
-66.52%-7.15M
Net Profit
4.97%-4.49M
35.92%-2.95M
13.81%-4.25M
7.63%-4.66M
12.53%-4.72M
14.07%-4.61M
6.29%-4.93M
-25.25%-5.04M
12.70%-5.40M
10.43%-5.37M
85.93%-5.26M
39.22%-4.03M
-46.40%-6.19M
11.83%-5.99M
-439.67%-37.38M
-16.61%-6.63M
47.59%-4.23M
-25.10%-6.79M
-30.04%-6.93M
-186.12%-5.68M
Current assets
-51.01%14.02M
-48.80%17.70M
-42.76%21.57M
-40.72%24.89M
-39.83%28.62M
-35.88%34.58M
-34.14%37.69M
-31.66%41.98M
-27.17%47.56M
-24.98%53.92M
-25.95%57.23M
-18.04%61.42M
-28.01%65.30M
-25.27%71.88M
-24.30%77.29M
-30.66%74.95M
-20.46%90.70M
172.23%96.18M
147.48%102.11M
195.09%108.08M
Total current liabilities
-12.92%3.31M
-45.29%3.07M
-2.62%4.57M
-3.23%4.31M
-28.61%3.81M
-14.83%5.61M
-8.59%4.69M
2.32%4.46M
0.89%5.33M
3.24%6.59M
-19.70%5.13M
29.76%4.36M
88.72%5.29M
41.12%6.38M
56.95%6.39M
-12.94%3.36M
-36.89%2.80M
29.01%4.52M
-2.61%4.07M
10.80%3.86M
Total assets
-51.49%14.06M
-49.31%17.74M
-43.04%21.76M
-40.90%25.16M
-39.92%28.98M
-36.00%35.00M
-34.24%38.20M
-31.74%42.57M
-27.27%48.24M
-25.11%54.69M
-26.03%58.09M
-27.38%62.37M
-27.48%66.33M
-24.71%73.03M
-23.41%78.53M
-20.93%85.88M
-20.19%91.46M
169.45%97.01M
144.03%102.54M
189.78%108.61M
Total liabilities
-12.68%3.39M
-44.71%3.14M
-2.58%4.64M
-4.17%4.38M
-29.43%3.88M
-16.40%5.69M
-11.55%4.76M
-1.61%4.58M
-2.24%5.50M
1.34%6.80M
-20.32%5.38M
24.36%4.65M
74.52%5.62M
33.99%6.71M
63.83%6.76M
-4.96%3.74M
-29.85%3.22M
33.19%5.01M
-8.98%4.13M
0.25%3.94M
Total equity
-57.49%10.67M
-50.20%14.60M
-48.80%17.12M
-45.32%20.77M
-41.27%25.10M
-38.79%29.32M
-36.56%33.44M
-34.17%37.99M
-29.59%42.74M
-27.79%47.89M
-26.57%52.70M
-29.73%57.71M
-31.21%60.70M
-27.91%66.32M
-27.07%71.77M
-21.53%82.14M
-19.79%88.24M
185.34%92.00M
162.53%98.41M
211.95%104.68M
Net operating income
42.93%-3.08M
28.25%-3.25M
-32.72%-3.34M
25.12%-3.96M
23.13%-5.40M
-11.28%-4.53M
29.72%-2.52M
-26.27%-5.28M
14.26%-7.03M
37.09%-4.07M
10.38%-3.58M
17.34%-4.18M
-45.27%-8.20M
-40.49%-6.47M
20.66%-4.00M
-9.40%-5.06M
29.25%-5.64M
17.30%-4.60M
-43.23%-5.04M
-202.75%-4.63M
Net investment
-100.00%0.00
-100.00%0.00
181.68%5.15M
-95.69%505.00K
46.54%9.43M
124.31%1.39M
-151.46%-6.30M
1715.59%11.71M
50.06%6.44M
-180.41%-5.71M
441.88%12.25M
-102.83%-725.00K
170.43%4.29M
-56.82%7.11M
-54.23%2.26M
328.79%25.63M
90.64%-6.09M
1708.57%16.46M
144.74%4.94M
-35.86%-11.20M
Net financing
886.96%181.00K
313.54%205.00K
--353.00K
100.00%64.00K
83.80%-23.00K
-500.00%-96.00K
100.00%0.00
-92.92%32.00K
-67.06%-142.00K
71.43%24.00K
93.94%-6.00K
1458.62%452.00K
49.40%-85.00K
-33.33%14.00K
-54.69%-99.00K
31.82%29.00K
-100.20%-168.00K
61.54%21.00K
-100.71%-64.00K
-99.77%22.00K

FAQs

What is the total revenue of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its total revenue reached 170.00K, with a year-on-year change of 1000.00K.

What are the current assets of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its current assets were 17.70M, with a year-on-year change of -48.80.

What are the total assets of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its total assets of Lisata Therapeutics Inc were 17.74M, with a year-on-year change of -49.31.

What are the total liabilities of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its total liabilities of Lisata Therapeutics Inc were 3.14M, with a year-on-year change of -44.71.

What is the total equity of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its total equity of Lisata Therapeutics Inc was 14.60M, with a year-on-year change of -50.20.

What is the net operating income of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its net operating income of Lisata Therapeutics Inc was -18.21M, with a year-on-year change of 18.74.

What is the net investment of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its net investment of Lisata Therapeutics Inc was 15.09M, with a year-on-year change of 14.00.

What is the net financing of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its net financing of Lisata Therapeutics Inc was 599.00K, with a year-on-year change of 390.78.

What is the Earnings Per Share (EPS) of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.91, with a year-on-year change of 20.43.

What is the net income of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its net income was -16.59M, with a year-on-year change of 17.01.

What is the net margin of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its net profit margin was -9756.47, with a year-on-year change of -388.19.

What is the Return on Equity (ROE) of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -74.67, with a year-on-year change of -45.19.

What is the Return on Assets (ROA) of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -62.89, with a year-on-year change of -41.13.

What is the operating profit of Lisata Therapeutics Inc?

According to Lisata Therapeutics Inc's FY2025 earnings report, its operating profit was -18.21M, with a year-on-year change of 18.74.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.